» Articles » PMID: 18547196

Incidental Findings in Genetics Research Using Archived DNA

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Despite calls by some commentators for disclosing incidental findings in genetics research, several factors weigh in favor of caution. The technology of genetics has the power to uncover a vast array of information. The most potent argument for restraint in disclosure is that much research is pursued without consent so that the individual participant may not know that research is being conducted at all. Often the work is done by investigators and at institutions with which the person has no prior contact. Past practice is also relevant; genetics researchers historically have chosen not to disclose incidental findings, of which misattributed paternity and pleiotropic alleles such as ApoE have been the most common. Many people choose not to have genetic tests when given a choice. It may be desirable to discuss the topic of incidental findings when consent for research is obtained, but given the risk of unwanted surprise when there has been no prior discussion, the potential utility of incidental findings should be very high before they are even offered to individuals.

Citing Articles

Algorithmic identification of persons with dementia for research recruitment: ethical considerations.

London A, Karlawish J, Largent E, Hey S, McCarthy E Inform Health Soc Care. 2024; 49(1):28-41.

PMID: 38196387 PMC: 11001531. DOI: 10.1080/17538157.2023.2299881.


Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?.

Garland A, Morain S, Sugarman J Am J Bioeth. 2022; 23(8):22-32.

PMID: 36449269 PMC: 10355327. DOI: 10.1080/15265161.2022.2146784.


Think Pragmatically: Investigators' Obligations to Patient-Subjects When Research is Embedded in Care.

Morain S, Largent E Am J Bioeth. 2022; 23(8):10-21.

PMID: 35435790 PMC: 9576818. DOI: 10.1080/15265161.2022.2063435.


Ethics and Collateral Findings in Pragmatic Clinical Trials.

Morain S, Weinfurt K, Bollinger J, Geller G, Mathews D, Sugarman J Am J Bioeth. 2020; 20(1):6-18.

PMID: 31896322 PMC: 7027922. DOI: 10.1080/15265161.2020.1689031.


A Belmont Reboot: Building a Normative Foundation for Human Research in the 21st Century.

Brothers K, Rivera S, Cadigan R, Sharp R, Goldenberg A J Law Med Ethics. 2019; 47(1):165-172.

PMID: 30994072 PMC: 6587582. DOI: 10.1177/1073110519840497.


References
1.
Biesecker B, Ishibe N, Hadley D, Giambarresi T, Kase R, Lerman C . Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet. 2000; 93(4):257-63. DOI: 10.1002/1096-8628(20000814)93:4<257::aid-ajmg1>3.0.co;2-8. View

2.
Pullman D, Hodgkinson K . Genetic knowledge and moral responsibility: ambiguity at the interface of genetic research and clinical practice. Clin Genet. 2006; 69(3):199-203. DOI: 10.1111/j.1399-0004.2006.00581.x. View

3.
Foster C, Evans D, Eeles R, Eccles D, Ashley S, Brooks L . Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test. 2004; 8(1):23-9. DOI: 10.1089/109065704323016003. View

4.
Pulley J, Brace M, Bernard G, Masys D . Attitudes and perceptions of patients towards methods of establishing a DNA biobank. Cell Tissue Bank. 2007; 9(1):55-65. DOI: 10.1007/s10561-007-9051-2. View

5.
Scheuner M . Genetic evaluation for coronary artery disease. Genet Med. 2003; 5(4):269-85. DOI: 10.1097/01.GIM.0000079364.98247.26. View